| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0009 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.002 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |